Octagon Capital Advisors »

Adlai Nortye Ltd Sponsored shares owned by Octagon Capital Advisors

Quarter-by-quarter ownership of Adlai Nortye Ltd Sponsored (ANL) shares owned by Octagon Capital Advisors from 13F filings

Historical chart of Octagon Capital Advisors investment in Adlai Nortye Ltd Sponsored

Tip: Access up to 7 years of quarterly data

All positions including Adlai Nortye Ltd Sponsored held by Octagon Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adlai Nortye Ltd Sponsored by Octagon Capital Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $11M 935k 11.50

More positions owned by Octagon Capital Advisors

Dianthus Therapeutics (DNTH)
Definium Therapeutics Com Shs (DFTX)
Abivax Sa Sponsored Ads (ABVX)
Cogent Biosciences (COGT)
Alumis (ALMS)
Arrivent Biopharma (AVBP)
Taysha Gene Therapies Com Shs (TSHA)
Bioage Labs (BIOA)
Mirum Pharmaceuticals (MIRM)
Kymera Therapeutics (KYMR)
Aktis Oncology (AKTS)
Xenon Pharmaceuticals (XENE)
Erasca Call Call Option
Palisade Bio (PALI)
Ocular Therapeutix (OCUL)

View all positions for Octagon Capital Advisors

Top funds holding Adlai Nortye Ltd Sponsored

Cormorant Asset Management
VR Adviser
Balyasny Asset Management
Point72 Asset Management
MPM Oncology Impact Management
Perceptive Advisors
Casdin Capital
ADAR1 Capital Management
Octagon Capital Advisors
Millennium Management
Braidwell
Squadron Capital Management
Eventide Asset Management
Superstring Capital Management
Adage Capital Partners GP

View all funds holding Adlai Nortye Ltd Sponsored